AtriCure cryoICE cryo-ablation probe (CRYO2)

AtriCure cryoICE cryo-ablation probe (CRYO2) is an FDA 510(k)-cleared medical device (K180138) manufactured by AtriCure, Inc.. This device is classified under the Neurology specialty. FDA Device Class II (Special Controls) — moderate risk, requires 510(k) clearance. FDA clearance granted on February 14, 2018. Regulation: 8.